Not enough data
Helena Beer's articles primarily focus on medical research, healthcare, treatment options, and drug approvals. Her coverage often cites data and press releases while also including government announcements. If you are considering reaching out to her, it would be beneficial to offer insights based on credible data or share expert opinions related to recent medical research findings or healthcare policies.
Given the nature of her coverage attributions, Helena appears inclined towards evidence-based reporting and may value pitches that provide access to reliable data sources or present in-depth analysis of new treatment options or pharmaceutical developments with a potential impact on public health.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Helena Beer
Four widely cited clinical sepsis phenotypes may not yet be suitable for universal clinical use or for guiding precision medicine strategies.
By: Helena Beer
A new multidisciplinary consensus statement offers guidance on the evaluation and work-up of sinonasal masses to reduce diagnostic errors.
A recent ASK Uveal Melanoma webinar is now available on-demand to inform clinicians of the clinical significance of this rare disease.
By: Helena Beer
Some commonly prescribed antihypertensive drug combinations, such as ARB-based regimens, may be better tolerated than monotherapy.
By: Helena Beer
João Gonçalves discusses how daraxonrasib has been positioned as a potential advance for previously treated metastatic pancreatic cancer.
By: Helena Beer
Prof Torsten Zuberbier discusses the GA²LEN ADCARE international consensus on topical corticosteroids for AD and inflammatory skin diseases.
By: Helena Beer
Dr Anders Neijber discusses bladder cancer progress and the trajectory to adopt current and future innovations in clinical practice.
By: Helena Beer
Prof Ramesh Kurukulaaratchy explains how multimorbidity patterns in severe asthma may help shift to more holistic, multidisciplinary care.
By: Helena Beer
SPCAF's Clare Depasquale discusses how research can strengthen the pharmacy workforce, patient care and future medicines optimisation.
By: Helena Beer
Respiratory conditions are becoming increasingly complex, placing greater demands on clinical teams, services and patient pathways.
